Research in Ristimäki Lab focuses on the molecular background of gastrointestinal tumors, mainly colorectal cancer and appendix-originating pseudomyxoma peritonei. In addition to understanding the molecular aberrations behind gastrointestinal tumorigenesis, our ultimate goal is to identify novel diagnostic biomarkers and therapy targets. Besides gene and protein level changes, we also study changes concerning cellular glycosylation.
Gastrointestinal tumorigenesis
Ari Ristimäki Group

Find Out More
Main Funding
Finnish Cancer Foundation, Finska Läkaresällskapet, Helsinki University Central Hospital Research Funds, Sigrid Jusélius Foundation, University of Helsinki